Clinical Trial Update: Phase 2 Dose-finding IMU-838 for Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of IMU-838 in ulcerative colitis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• IMU-838 (IMU-838)

Snippet

Sponsor: Immunic AG | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2024-03-05